RC
RegentAtlantic Capital Portfolio holdings
AUM
$3.34B
1-Year Return
14.53%
This Quarter Return
+19.35%
1 Year Return
-14.53%
3 Year Return
+23.5%
5 Year Return
+45.33%
10 Year Return
–
AUM
$1.8B
AUM Growth
+$512M
(+40%)
Cap. Flow
+$299M
Cap. Flow
% of AUM
16.68%
Top 10 Holdings %
Top 10 Hldgs %
35.62%
Holding
492
New
76
Increased
227
Reduced
151
Closed
16
Top Buys
| 1 |
Vanguard Growth ETF
VUG
|
$148M |
| 2 |
Vanguard Real Estate ETF
VNQ
|
$65.3M |
| 3 |
Schwab International Equity ETF
SCHF
|
$21.1M |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
$15.2M |
| 5 |
Walmart
WMT
|
$6.85M |
Top Sells
| 1 |
Vanguard Global ex-US Real Estate ETF
VNQI
|
$10.8M |
| 2 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
$7.8M |
| 3 |
RTN
Raytheon Company
RTN
|
$5.69M |
| 4 |
Lennar Class A
LEN
|
$3.05M |
| 5 |
Capital One
COF
|
$2.93M |
Sector Composition
| 1 | Technology | 16.65% |
| 2 | Healthcare | 11.13% |
| 3 | Financials | 9.43% |
| 4 | Communication Services | 7.73% |
| 5 | Industrials | 5.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
451
Sherwin-Williams
SHW
$92.9B
| $204K | 0.01% |
+1,059
| New | +$204K |
|
452
Dell
DELL
$84.4B
| $203K | 0.01% |
+7,302
| New | +$203K |
|
453
GSK
GSK
$81.5B
| $203K | 0.01% |
+3,977
| New | +$203K |
|
454
American Water Works
AWK
$28B
| $202K | 0.01% |
+1,573
| New | +$202K |
|
455
BCE
BCE
$23.1B
| $202K | 0.01% |
+4,844
| New | +$202K |
|
456
Cboe Global Markets
CBOE
$24.3B
| $200K | 0.01% |
+2,144
| New | +$200K |
|
457
Empire State Realty Series ES
ESBA
$2.15B
| $200K | 0.01% |
27,338
| – | – |
|
458
TEGNA Inc
TGNA
$3.38B
| $195K | 0.01% |
17,514
-11,669
| -40% | -$130K |
|
|
MRO
459
DELISTED
Marathon Oil Corporation
MRO
| $178K | 0.01% |
+29,157
| New | +$178K |
|
460
Amcor
AMCR
$19.1B
| $156K | 0.01% |
15,259
+3,701
| +32% | +$37.8K |
|
461
Equinor
EQNR
$60.1B
| $149K | 0.01% |
10,296
-3,826
| -27% | -$55.4K |
|
462
Kayne Anderson Energy Infrastructure Fund
KYN
$2.08B
| $135K | 0.01% |
25,510
| – | – |
|
|
BMY.RT
463
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $108K | 0.01% |
30,076
+2,280
| +8% | +$8.19K |
|
464
Ford
F
$46.7B
| $98K | 0.01% |
16,127
+1,464
| +10% | +$8.9K |
|
|
GMZ
465
DELISTED
Goldman Sachs MLP Income Opportunities Fund
GMZ
| $96K | 0.01% |
+10,000
| New | +$96K |
|
466
Energy Transfer Partners
ET
$59.7B
| $85K | ﹤0.01% |
11,975
-109
| -0.9% | -$774 |
|
467
SiriusXM
SIRI
$8.1B
| $85K | ﹤0.01% |
1,443
+105
| +8% | +$6.19K |
|
468
Tilray
TLRY
$1.31B
| $78K | ﹤0.01% |
+10,924
| New | +$78K |
|
469
LiveOne
LVO
$51.2M
| $63K | ﹤0.01% |
+17,281
| New | +$63K |
|
470
Brookdale Senior Living
BKD
$1.83B
| $44K | ﹤0.01% |
15,000
| – | – |
|
|
CMMB
471
Chemomab Therapeutics
CMMB
$16M
| $34K | ﹤0.01% |
+391
| New | +$34K |
|
472
Opko Health
OPK
$1.07B
| $34K | ﹤0.01% |
+10,000
| New | +$34K |
|
473
VYNE Therapeutics
VYNE
$7.62M
| $26K | ﹤0.01% |
+213
| New | +$26K |
|
474
Matinas BioPharma
MTNB
$9.55M
| $15K | ﹤0.01% |
400
| – | – |
|
|
NMTR
475
DELISTED
9 Meters Biopharma, Inc. Common Stock
NMTR
| $7K | ﹤0.01% |
+600
| New | +$7K |
|